Polycystic Liver Disease - 8 Studies Found

Completed : Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
: Polycystic Liver Disease
: 2011-01-11
: Drug: Lanreotide Autogel 90 mg and 120 mg administration of lanreotide sc every 4 weeks (28 days)
Terminated : Polycystic Liver Disease in Kidney Transplant
: Polycystic Liver Disease
: 2009-07-06
:
  • Drug: Tacrolimus Tacrolimus 6-
Terminated : Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
: Polycystic Liver Disease
: 2014-06-20
: Other: PLD-Q polycystic liver disease questionnaire
Completed : Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
:
  • Polycystic Liver Disease (PLD):
  • Polycystic Kidney, Autosomal Do
    : 2013-12-12
    : Drug: Ursodeoxycholic Acid The intervention group will receive 15-20mg/kg/day UDCA for 24 weeks
Active, not recruiting : Pasireotide LAR in Severe Polycystic Liver Disease
:
  • Somatostatin Analogs
  • Polycystic Liver Disease
  • Drug: Pasireotide LAR Injectib
Completed : Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
: Polycystic Liver Disease
: 2011-05-13
: Drug: Lanreotide 120 mg every 28 days intramuscular
Completed : Everolimus and LongActing Octreotide Trial in Polycystic Livers
: Polycystic Liver Disease
: 2010-07-06
:
  • Drug: Everolimus 2.5 mg every

Completed : The Vienna RAP Pilot Study
: ADPKD
: 2012-05-13
: Drug: Sirolimus Coated tablets, 1mg and 2mg available. Daily oral single dose with trough levels of 4-8n